At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...